Red flag symptoms requiring urgent medical attention include: Severe, persistent abdominal pain , particularly in the upper abdomen or epigastric region, which could indicate pancreatitis (a rare but serious adverse effect of GLP-1 therapy) Difficulty swallowing (dysphagia) or painful swallowing (odynophagia) Unintentional weight loss beyond expected therapeutic effects Persistent vomiting that prevents adequate oral intake or medication administration Right upper quadrant pain, fever, or yellowing of skin/eyes , which could indicate gallbladder disease (a known risk with weight loss on GLP-1 therapies) Symptoms of gastroparesis such as early satiety, postprandial fullness, or vomiting undigested food Call 911 or seek emergency care immediately for: Severe chest pain that could represent cardiac pathology rather than reflux Evidence of gastrointestinal bleeding , including black, tarry stools or vomiting blood or coffee-ground material If you suspect pancreatitis (persistent severe abdominal pain, sometimes radiating to the back, with or without nausea/vomiting), stop taking the GLP-1 medication immediately and seek urgent medical care, as directed in FDA prescribing information

Never stop either medication without explicit guidance from your prescribing physicians, as sudden discontinuation can trigger rebound effects in appetite, blood sugar, and inflammation
About 20% of Americans have high levels of Lp(a), which can double the risk of a heart attack and is linked with conditions like stroke and aortic valve stenosis
The Nose and Nasal Breathing in Sleep Apnea
Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis
Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons